•  
  •  
  •  
  •  

2025-12-23 18:16:10

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Biocon Ltd signs out-licensing agreement with Ajanta to market Semaglutide in 26 countries
  • Axis Bank Launches Digital Merchant Cash Advance Loans for MSMEs
  • Shakti Pumps India Ltd receives LoA worth Rs. 356.77 crores from MSEDCL
  • Surana Telecom and Power Ltd awarded 8 LOAs for 51.3 MW solar projects
  • Vikran Engineering Ltd accepts order received from Onix Renewables Ltd

Keywords Selected:  USA

Research

  • 45% of Newbie traders claim that 'not knowing enough' is the primary reason for losses incurred in Futures & Options trading - Sharekhan's survey reveals
  • Domestic primary aluminium manufacturing entities are behind the curve in the transition to a greener future: ICRA
  • Campus Activewear - IPO - Strong Business Model, but Valuation is Stretched

Stock Report

  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial
  • AION-Tech Solutions and Bulgarian Company Theoremus AD Sign MoU to Advance Multimodal Urban Mobility in India
  • Aion-Tech Solutions Ltd enters into MoU with Theoremus AD
  • Powerhouse Engines Selects Ramco Systems to Transform Engine MRO Operations
  • Sathgen Therapeutics Division expands to the U.S. with Launch of Princeton Based Subsidiary
  • Fineotex Chemical Ltd announces Strategic Acquisition of a Leading U.S. Specialty Oilfield Chemicals Group
  • Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg™ in the United States
  • Godavari Biorefineries Inc forms subsidiary in USA
  • Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S.
  • Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial
  • XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector
  • Lupin Launches Authorized Generic Version of Ravicti® in the United States
  • Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP
  • M & B Engineering Ltd's subsidiary secures export order from USA
  • KRN HVAC Products Pvt Ltd commences commercial production of Bus AC Division
  • Lupin gets one observation from USFDA for Somerset, New Jersey manufacturing facility
  • Emmforce Autotech Ltd secures prestigious order worth Rs. 10.50 crores
  • AccelerateBS India Ltd signs non-binding MOU to acquire company in USA
  • High Street Filatex Ltd is now Tusaldah Ltd
  • KRN HVAC Products Pvt Ltd to acquire Bus Air-Conditioning division of SRSPL
  • Optiemus Infracom and Ordinary Theory USA announce JV to Manufacture & Market 'Made in India' Smart Enterprise Hardware & Industrial Solutions
  • Waaree Energies' Continued Commitment to U.S. Manufacturing and Regulatory Compliance
  • SpiceJet bolsters Fleet with Airbus A340 Wide‐Body Aircraft Lease Agreement
  • Spice Lounge Food Works Ltd to invest in Teksoft Systems INC

Industry News

  • LiaPlus AI raises INR 2 Crore in Seed Round led by Inflection Point Ventures

Latest Post

  • Biocon Ltd signs out-licensing agreement with Ajanta to market Semaglutide in 26 countries
  • Axis Bank Launches Digital Merchant Cash Advance Loans for MSMEs
  • Shakti Pumps India Ltd receives LoA worth Rs. 356.77 crores from MSEDCL
  • Surana Telecom and Power Ltd awarded 8 LOAs for 51.3 MW solar projects
  • Vikran Engineering Ltd accepts order received from Onix Renewables Ltd


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024